Simplifying Global Compliance
EMA Confirms Suspension of Drugs Over Flawed Studies
Clinical Trials Advisor
The European Medicines Agency has confirmed plans to halt sales of 700 drug forms and strengths authorized based on clinical studies performed by Hyderabad, India-based GVK Biosciences.
To View This Article:
Subscribe To Clinical Trials Advisor
Buy This Article Now
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing